Natural Confidence Renewed.

BOTOX® ASK YOUR HEALTH CARE PROFESSIONAL IF BOTOX® IS RIGHT FOR YOU. BOTOX® is an unfunded medicine for aesthetic procedures so you will need to pay for the medicine and any other charges. BOTOX® is a Prescription Medicine containing 50, 100 or 200 units of clostridium botulinum Type A toxin complex for injection. It is used for the treatment of frown lines, crows feet and horizontal forehead lines. It should be administered only by trained medical professionals. Cautions: people with defective neuro-muscular transmission disorders, presence of infection at site of injection, glaucoma, pregnancy and lactation. Possible side effects include headaches, pain, burning or redness at injection site, local muscle weakness including drooping eye lids, lack of feeling & nausea. Talk to your specialist about the benefits/risks of this procedure or if you have concerns or side effects. For more information, please refer to the BOTOX® Consumer Medicine Information on the MEDSAFE website http://www.medsafe.govt.nz Note: BOTOX® treatment lasts about four months and after this time further courses of treatment may be necessary. Speak to your specialist about your own situation. BOTOX® and its design are trademarks of Allergan, Inc., an AbbVie company.

DYSPORT® ASK YOUR HEALTH CARE PROFESSIONAL IF DYSPORT® IS RIGHT FOR YOU. Dysport® is an unfunded medicine for aesthetic indications. Product and treatment costs apply. Dysport® is a prescription medicine contains 300 or 500 U of botulinum toxin, distributed in NZ by Galderma Australia Pty Ltd, North Sydney, NSW, for the treatment of frown lines and crow's feet around the eyes. Dysport® has risks and benefits. Ask your healthcare professional if Dysport® is right for you and to explain the possible side effects. Tell them if any side effects concern you. ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. For details on precautions and side effects, see the Consumer Medicines Information at www.medsafe.govt.nz. Dysport® is a registered trademark of Ipsen Pty Ltd. Galderma is a registered trademark of Galderma Holding S.A.

PROFHILO® ASK YOUR HEALTH CARE PROFESSIONAL IF PROFHILO® IS RIGHT FOR YOU. PROFHILO® and PROFHILO® Body is an unfunded medicine so you will need to pay for the medicine and any other charges. PROFHILO® and PROFHILO® Body are Class III medical devices containing 16mg high molecular weight (MW) hyaluronic acid (HA) + 16mg low MW HA/1mL syringe that is obtained through a patented treatment (NAHYCO® Hybrid Technology) which provides it with unique characteristics for its use in the face and body, where it is injected with an ultrafine needle to plump the skin to smooth away wrinkles and improve texture and skin quality. PROFHILO® must only be administered by a medical practitioner or a qualified nurse injector (who operates under the supervision of a medical practitioner). Treatment costs and normal practitioner's fees will apply. PROFHILO® has risks and benefits. Do not use with treatments such a laser resurfacing or medium deep skin-peeling. Do not inject into inflamed areas or intravenously or intramuscularly. Please consult your medical practitioner regarding its suitability for you, or if there are any questions regarding precautions and side effects. For further product information, please refer to your medical practitioner or the Instructions for Use leaflet at Dermocosmètica PTY LTD, Australia. PROFHILO® is a registered trademark of IBSA.

SUNEKOS® ASK YOUR HEALTH CARE PROFESSIONAL IF SUNEKOS® IS RIGHT FOR YOU. SUNEKOS® is an unfunded medicine so you will need to pay for the medicine and any other charges. SUNEKOS® is a Class III medical devices containing a patented formula of HA and amino acids. SUNEKOS® is a resorbable injection solution that modifies the structure of mature skin, restoring volume, filling wrinkles and folds in the skin and in scar sites. SUNEKOS® has risks and benefits. SUNEKOS® should not be used on patients: with known hypersensitivity to any of its components; presenting with a general infection, inflammation or irritation in the area to be treated; or in patients predisposed to coagulation disorders. A local reaction may rarely occur, caused by hypersensitization phenomena, with symptoms that include oedema and sensation of burning and/or itching. These reactions normally resolve within two days. Consult your healthcare professional to see if SUNEKOS® is right for you. For more information refer to the instructions for use. New Zealand Sponsor: AA-Med Pty Ltd Distributed by: Xytide Biotech NZ Pty LTD.